GenomOncology is proud to announce the appointment of Dr. Jonathan “Jack” Lord, M.D., to its Board of Directors. A nationally recognized leader in healthcare innovation, Dr. Lord brings a wealth of expertise in driving change through new technologies and therapies, making him an ideal fit for GenomOncology’s mission to advance precision medicine in oncology.
Your privacy is our priority
- Hosted on Secure cloud-based hosting
- SOC II Type 1
- HIPAA compliant
- 2FA authentication
- End-to-end data encryption
- Your health data will not be sold or used without your consent. Ever.